Literature DB >> 22989702

Growth inhibition and induction of apoptosis in human cancerous HeLa cells by Maytenus procumbens.

S Momtaz1, A A Hussein, S N Ostad, M Abdollahi, N Lall.   

Abstract

The possible biochemical activities of the acetonic/ethanolic extract of the leaves of Maytenus procumbens (L.M.P), and its isolated compounds were investigated in the present study. In cytotoxicity assay, L.M.P showed IC(50) of 68.79, 51.22, 78.49, 76.59, and 76.64μg/ml on Caco-2, HeLa, HT29, NIH3T3, and T47D cells, respectively. Bioassay guided fractionation led to the isolation and identification of a new triterpene: '30-hydroxy-11α-methoxy-18β-olean-12-en-3-one' (HMO) in addition to a known terpenoid: 'asiatic acid' (AA). HMO exhibited the most cytotoxicity against HeLa cells and was further investigated for its ability to induce apoptosis in HeLa cells. HMO induced apoptosis up to 20.41% in HeLa cells versus control group (0.40%). Antioxidant/oxidative properties of L.M.P and HMO were investigated using extracellular (DPPH), and intracellular (ROS) assays. Experimental samples represented a time and concentration-dependent formation of ROS in Hela cells. Generation of ROS seems one of the mechanisms by which HMO induces apoptosis in Hela cells. Conclusion is that the active components in L.M.P might serve as a mediator of the ROS scavenging system and have the potential to act as prooxidant or antioxidant depending on the biological environment of the cells.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22989702     DOI: 10.1016/j.fct.2012.09.005

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

Review 1.  Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise.

Authors:  Mohamed Fizur Nagoor Meeran; Sameer N Goyal; Kapil Suchal; Charu Sharma; Chandragouda R Patil; Shreesh K Ojha
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

2.  Anti-inflammatory activity and qualitative analysis of different extracts of Maytenus obscura (A. Rich.) Cuf. by high performance thin layer chromatography method.

Authors:  Mohamed F Alajmi; Perwez Alam
Journal:  Asian Pac J Trop Biomed       Date:  2014-02

3.  Evaluation of Rumex hastatus D. Don for cytotoxic potential against HeLa and NIH/3T3 cell lines: chemical characterization of chloroform fraction and identification of bioactive compounds.

Authors:  Sajjad Ahmad; Farhat Ullah; Anwar Zeb; Muhammad Ayaz; Farman Ullah; Abdul Sadiq
Journal:  BMC Complement Altern Med       Date:  2016-08-24       Impact factor: 3.659

4.  Maytenus disticha Extract and an Isolated β-Dihydroagarofuran Induce Mitochondrial Depolarization and Apoptosis in Human Cancer Cells by Increasing Mitochondrial Reactive Oxygen Species.

Authors:  Iván González-Chavarría; Felix Duprat; Francisco J Roa; Nery Jara; Jorge R Toledo; Felipe Miranda; José Becerra; Alejandro Inostroza; Alexandra Kelling; Uwe Schilde; Matthias Heydenreich; Cristian Paz
Journal:  Biomolecules       Date:  2020-02-29

5.  Evaluation of pharmacological activities, cytotoxicity and phenolic composition of four Maytenus species used in southern African traditional medicine to treat intestinal infections and diarrhoeal diseases.

Authors:  Aroke Shahid Ahmed; Lyndy J McGaw; Jacobus N Eloff
Journal:  BMC Complement Altern Med       Date:  2013-05-11       Impact factor: 3.659

6.  Testicular Dysfunction Ameliorative Effect of the Methanolic Roots Extracts of Maytenus procumbens and Ozoroa paniculosa.

Authors:  Nkosinathi David Cele; Nonhlakanipho Felicia Sangweni; Rebamang Anthony Mosa; Dambudzo Penduka; Geraldine Genevive Lazarus; Moganavelli Singh; Godfrey Elijah Zharare; Andy Rowland Opoku
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-19       Impact factor: 2.629

7.  Anticancer effect of the traditional Chinese medicine herb Maytenus compound via the EGFR/PI3K/AKT/GSK3β pathway.

Authors:  Baozhen Zeng; Chunlei Ge; Wentao Zhao; Kaicong Fu; Lin Liu; Zhuying Lin; Qiaofen Fu; Zhen Li; Ruilei Li; Huan Guo; Chunyan Li; Liufang Zhao; Hongyan Hu; Hanyu Yang; Wenhua Huang; Youguang Huang; Xin Song
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.